Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mayu Sugai
Observed names:
M. Sugai,
Sugai, Mayu
Institutions:
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
Observed institutions:
Iwate University,
Iwate Medical University,
The Cancer Institute Hospital,
Japanese Foundation For Cancer Research
ORCID:
0000-0003-2801-2196
Observed ORCID:
0000-0003-2801-2196
OpenAlex ID:
A5007732859
The new IASLC grading system for invasive non‐mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems
2022
·
Naoki Yanagawa
, Mayu Sugai
, et al.
·
Journal of Surgical Oncology
·
27
Impact of immune-related adverse event severity on overall survival in patients with advanced NSCLC receiving immune checkpoint inhibitors therapy, with a focus on combination regimens
2025
·
Mayu Sugai
, Yoshiaki Amino
, et al.
·
Lung Cancer
·
21
PDF
Serum CYFRA 21-1 as a Prognostic Marker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
2024
·
Keiki Miyadera
, Sho Kakuto
, et al.
·
Cancers
·
17
PDF
Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR ‐mutated lung cancer
2021
·
Takashi Ito
, Hiromi Nagashima
, et al.
·
Thoracic Cancer
·
17
PDF
High expression of fibroblast‐activating protein is a prognostic marker in non‐small cell lung carcinoma
2022
·
Naoki Yanagawa
, Mayu Sugai
, et al.
·
Thoracic Cancer
·
16
Correlation of tumor microenvironment-related markers with clinical outcomes in patients with squamous cell carcinoma of the lung
2022
·
Mayu Sugai
, Naoki Yanagawa
, et al.
·
Translational Lung Cancer Research
·
16
PDF
Desmoplastic reactions and epithelial-mesenchymal transition proteins in stages II and III colorectal cancer: association with and prognostic value for disease-free survival
2022
·
Mai Hashimoto
, Noriyuki Uesugi
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
15
Surgical treatment for lung metastasis of inflammatory myofibroblastic tumor of the lung: A case report
2023
·
Hidenobu Iwai
, Naoki Yanagawa
, et al.
·
Thoracic Cancer
·
13
PDF
Low‐grade fibromyxoid sarcoma arising from the lung: A case report
2021
·
Ryuichi Yoshimura
, Masao Nishiya
, et al.
·
Thoracic Cancer
·
13
PDF
Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung
2023
·
Shunsuke Shikanai
, Noriyuki Yamada
, et al.
·
Annals of Surgical Oncology
·
12
PDF
Prognostic and predictive value of CD163 expression and the CD163 / CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinoma
2023
·
Naoki Yanagawa
, Shunsuke Shikanai
, et al.
·
Thoracic Cancer
·
12
PDF
A case of bone marrow involvement in sarcoidosis with crescentic glomerular lesions
2020
·
Mayu Sugai
, Okinori Murata
, et al.
·
Respiratory Medicine Case Reports
·
6
PDF
Characteristics and prognostic analysis of patients with detected KRAS mutations in resected lung adenocarcinomas by peptide nucleic acid-locked nucleic acid polymerase chain reaction (PNA-LNA PCR) clamp method
2023
·
Tatsuya Hashimoto
, Yoshihisa Owada
, et al.
·
Translational Lung Cancer Research
·
3
PDF
Prognostic impact of tumor microenvironment-related markers in patients with adenocarcinoma of the lung
2022
·
Mayu Sugai
, Naoki Yanagawa
, et al.
·
International Journal of Clinical Oncology
·
2
PDF
Prognostic value of serum CYFRA21-1 in locally advanced non-small cell lung cancer undergoing durvalumab consolidation therapy after chemoradiotherapy
2026
·
Masahiro Ito
, Ryo Ariyasu
, et al.
·
Lung Cancer
·
1
Prognostic impact of HNF4α expression in TTF-1-negative non-squamous NSCLC treated with immune checkpoint inhibitor
2025
·
Hirokazu Iso
, Ryo Ariyasu
, et al.
·
Lung Cancer
·
1
Frequency of cis and trans EGFR T790M and activation mutations in tumors treated with EGFR inhibitors
2020
·
平野, 邦夫
, 渡邉, 香奈
, et al.
·
Institutional Repositories DataBase (IRDB)
·
1
Real‐World Survival Over 25 Years in Extensive‐Stage Small‐Cell Lung Cancer: The Impact of Immune Checkpoint Inhibitors
2026
·
Ryo Ariyasu
, Teruhisa Nemoto
, et al.
·
Thoracic Cancer
Early vs late survival patterns of chemoimmunotherapy compared with immune checkpoint inhibitor monotherapy in non–small cell lung cancer.
2026
·
Ryo Ariyasu
, Teruhisa Nemoto
, et al.
·
Journal of Clinical Oncology
PDF
1094eP Impact of PD-L1 expression and tumor-infiltrating lymphocytes on the efficacy of anti-PD-1/L1 and anti-CTLA-4 therapies in advanced non–small cell lung cancer
2025
·
M. Sugai
, K. Uchibori
, et al.
·
Annals of Oncology
A case of radical surgery for primary lung cancer with idiopathic dilatation of the pulmonary artery: a case report
2025
·
Wataru Shigeeda
, Makoto Tomoyasu
, et al.
·
General Thoracic and Cardiovascular Surgery Cases
ASO Visual Abstract: Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung
2023
·
Shunsuke Shikanai
, Noriyuki Yamada
, et al.
·
Annals of Surgical Oncology
PDF
Prognostic and predictive value ofTTF-1 expression in patients with recurrent or advanced lung adenocarcinoma without sensitizing EGFR mutations or ALK translocation treated with platinum-based chemotherapy
2023
·
Mayu Sugai
, Naoki Yanagawa
, et al.
·
Research Square
PDF
肺腺癌患者における癌微小環境関連マーカーの予後への影響
2022
·
Sugai, Mayu
·
Institutional Repositories DataBase (IRDB)
Show more works
View as search
Works count:
24
Citation count:
193
H-index:
11
I10-index:
11
Year
Topic
Type